CD8A and cancer: Although it remains uncertain whether MAL-associated TCR-signaling T cells specifically differentiate into CD8 (+) T cells, in the immune response against cancer cells, TCR signaling has been reported to preferentially activate and promote the proliferation of CD8 (+) T cells [36,37].